ELUT Stock Analysis: Buy, Sell, or Hold?
ELUT - Elutia Inc. Class A Common Stock
$1.05
0.00 (0.00%)
▲
HOLD
MODERATE Confidence
Last Updated: January 30, 2026
Earnings: Mar 05, 2026
Get Alerted When ELUT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD - EXTENDED: ELUT is 10.5% above fair value ($0.95). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
📊 HOLD - EXTENDED: ELUT is 10.5% above fair value ($0.95). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
In-depth Analysis How we analyze
Valuation Analysis: ELUT is currently trading at $1.05, which is considered extended relative to its 30-day fair value range of $0.59 to $0.95.
Technical Outlook: Technically, ELUT is in a downtrend. Immediate support is located at $0.74, while resistance sits at $1.15.
Market Sentiment: ELUT has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $3.50 (+233.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, ELUT is in a downtrend. Immediate support is located at $0.74, while resistance sits at $1.15.
Market Sentiment: ELUT has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $3.50 (+233.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Fair Price Range
$0.59 -
$0.95
Company Quality Score
54/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
52.6%
Protect Your Profits
ELUT is technically overbought (RSI 71). Consider hedging now to protect against a potential pullback while keeping your upside.
View Profit Protection PlanAll Signals
- BEARISH: Price significantly overextended (+10.5% above fair value)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 233.3% below Wall St target ($3.50)
Fair Price Analysis
30-Day Fair Range
$0.59 -
$0.95
Current vs Fair Value
EXTENDED
Support & Resistance Levels
Support Level
$0.74
Resistance Level
$1.15
Current Trend
Downtrend
Fundamental Context
Forward P/E (Next Year Est.)
-2.08
Wall Street Target
$3.50
(+233.3%)
Revenue Growth (YoY)
-9.3%
Profit Margin
-121.7%
Last updated: January 30, 2026 4:02 PM ET
Data refreshes hourly during market hours. Next update: 5:02 PM
Data refreshes hourly during market hours. Next update: 5:02 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ELUT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$124 | 59 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
26 analysts |
$85 | 65 BUY |
|
ABT
Abbott Laboratories |
BUY
28 analysts |
$136 | 63 BUY |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$110 | 63 BUY |
|
PODD
Insulet Corporation |
STRONG BUY
23 analysts |
$374 | 54 HOLD |
Advanced ELUT Option Strategies
Professional options setups generated by AI based on today's ELUT price and gamma walls.
